Recent Updates
Recently added Catalysts

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $19.00/ Month

  • Searchable FDA calendar providing data readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Download all the data in Excel sheet
  • Track biotech earnings and catalyst events
  • Monitor insider trading and hedge fund holdings
  • Advanced portfolio management tools
  • Research on over 1,100 companies and clinical trials
  • Get real-time market updates
  • Learn with exclusive courses
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $19.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics

Unlock the Full Potential with BPW Elite Plus

Features

Free Plan

Elite Plus

Recommended
Catalysts Calendars and Probability of Approval
PDUFA Calendar
Basic access to key PDUFA dates
Full access to upcoming PDUFA dates, Probability of Approval (PoA), historical data with advanced filters, and insights into market-moving FDA decisions.
FDA Calendar
Limited access with only upcoming 6 events
Full access to clinical trial readouts from pre-clinical to Phase 3, PDUFA catalysts, top-line results, and regulatory milestones with PoA. Filters by therapeutic area or disease, and much more.
Probability of Approval (PoA)
Not included
Detailed insights into the likelihood of drug approvals using historical trends and clinical performance metrics.
Historical FDA/PDUFA and Run-up or Run-down
Not included
Full access to historical PDUFA dates and clinical readouts with run-up and run-down performance analytics and advanced filters to analyze past trends and outcomes.
Market Movers
Basic insights into top movers
Comprehensive analysis of stocks impacted by FDA approvals, clinical data, and key catalysts.
Earnings, Trials, and Conference
Biotech Earnings Calendar
Not included
Full access to all biotech earnings events, including historical EPS and financial trends.
Conference Calendar
Not included
Full access to all biotech and pharma conferences, including schedules, presentations, and key updates.
Clinical Trial Quick Summary
Not included
Concise summaries of trials, including phases, target conditions, and expected completion dates.
Research and Screening
Company Screener
Not included
Comprehensive insights into company health, drug pipelines, financial metrics, and more.
CatalystSync™ Discovery and Filters
Not included
Find actionable catalysts fast. Filter by phase, disease, price action, and liquidity; search tickers; save views; export to Excel; get alerts.
Analyst Ratings and Sentiment Score
Not included
Analyst ratings, consensus, and sentiment scoring across covered tickers.
Positioning and Signals
Insider Trades
Not included
Full insights into insider buying and selling activity for biotech and pharma stocks.
Hedge Fund Screener
Not included
Full access to 54 bio hedge fund holdings, strategies, and activity focused on biotech investments.
All Stock Holdings
Not included
Advanced filters to analyze hedge fund and institutional confidence in top biotech and pharma stocks.
Options Data and Strategies
Not included
Options flow with strategy modules, including screeners and playbooks.
News, Alerts & Real-time Data
News and Alerts
Live news preview with basic alerts
Live news feed with customizable alerts for tickers, drugs, and indications.
Real-time Market Data
Not included
Real-time market updates, trends, and analysis.
Filters, Exports & Workflow
Advanced Filters and Saved Views
Basic filtering
Powerful multi-select filters for phase, therapeutic area, catalyst window, fund activity, sentiment, and options signals with saved views.
Download Datasets in Excel
Not included
Download FDA or PDUFA catalysts, biotech profiles, conference schedules, insider trades, and all platform data with Download Credits for smarter investment decisions.
Support & Extras
Support
Community support
Priority email support for quick resolutions and assistance.
Education
Not included
Exclusive courses on biotech investment basics.
Annual Bonus
Not included
Quarterly 30 min strategy call with the annual plan.

• Programmatic Access

Build with the BiopharmaWatch API

Access the entire BiopharmaWatch data platform directly from your code.
Power your quant models, trading systems, and research dashboards with institutional-grade biotech data.

Read the full API reference
/api/v2/fdacalendarUpcoming FDA catalyst events
/api/v2/pdufa/upcomingUpcoming PDUFA approval dates
/api/v2/pdufa/historicalPast PDUFA decisions & outcomes
/api/v2/catalystsyncCatalyst discovery & filtering
/api/v2/fdacalendar/historicalHistorical FDA calendar data
BiopharmaWatch API Basic

For developers building internal tools, trackers, and their own apps on BiopharmaWatch data.

$99/month

Billed annually at $1,190/year

  • Complete FDA calendar with upcoming clinical readouts and PDUFA dates
  • Probability of Approval (PoA) summary and deep scorecards
  • 5+ years of PDUFA data with decision outcomes and approval status
  • Historical catalyst data with price movements and key event metadata
  • Clinical-pipeline database, auto-updated across all monitored companies
  • SEC financial health: runway, burn, dilution and distress signals
  • Unusual-volume alerts, company universe, holders, gainers/losers
  • JSON response format with secure API key authentication
  • 100 requests/min
BiopharmaWatch API Elite Plus

For quants, funds, and data-driven investors who want the full proprietary signal layer.

$189/month

Billed annually at $2,268/year

  • Everything in API Basic, plus full real-time platform access
  • Exclusive to Elite Plus
  • Company & pipeline scoring: risk-adjusted NPV (rNPV) and valuation signals
  • M&A target scores, deal tracker, and acquirer leaderboard
  • Pipeline health grades and competitive landscape intelligence
  • Hedge-fund positioning and insider-trading activity (Smart Money)
  • Conviction-weighted hedge-fund sentiment scores
  • Proprietary machine-learning clinical-trial results and risk signals
  • FDA designations, approvals and adverse-event safety signals
  • Options flow, options chain and put-call analytics
  • Analyst ratings, price targets and firm actions
  • 1,000 requests/min with full historical depth and priority support
  • Free setup consultation call for custom integration needs

Simple integration: just add your API key

GET https://api.biopharmawatch.com/api/v2/fdacalendar?apiKey=YOUR_KEY

• FAQs

The FDA Calendar lists upcoming biotech catalysts, including clinical readouts (preclinical through Phase 3), PDUFA decisions, top-line results, advisory committee dates, and key regulatory milestones. You can filter by therapeutic area, disease, stage, and timing, and set alerts so you never miss a window.

Yes. The dedicated PDUFA calendar shows upcoming FDA approval dates, changes, and outcomes. Elite Plus includes full historical PDUFA data with run-up and run-down analytics so you can study how price typically moves into and after decisions.

Catalyst data is manually updated twice daily, while the rest of the data, including real-time financials and market trends, is updated continuously throughout the day.

We use company press releases, SEC filings, clinical registries, investor decks, scientific publications, and conference posters and schedules. Each item is standardized so you can compare across companies.

PoA scorecards estimate the likelihood of approval using indication-specific base rates, trial design, and historical outcomes. Use PoA to compare risk-reward across assets and align position size to probability.

Yes. Elite Plus includes Excel exports for FDA and PDUFA catalysts, company and pipeline profiles, conference schedules, insider trades, and other datasets to feed your models.

Yes. The API provides programmatic access to FDA events, PoA, historical catalysts, insider and hedge fund data, pipelines and much more.

Yes, you can cancel anytime through your ‘My Subscription’ page. Simply click your profile picture in the top right menu. You can also reach out to us at contact@biopharmawatch.com for assistance.

Free is a preview only. Elite Plus unlocks full coverage, alerts, PoA, options, analyst ratings, exports, and more. Annual billing typically saves 21% and includes a quarterly 30-minute strategy call.
FAQ
Still Have Questions?

Can't find the answer you're looking for? Please chat to our friendly team.

See Why Professionals Choose BiopharmaWatch
Join 12,400+ Investors who are already making profits

Since using BiopharmaWatch, my trades tied to biotech events have been 30% more successful. The FDA Calendar is like my secret weapon for timing the market always detailed and up-to date!

FlagSan Francisco, CA, USA

My portfolio is up 23% since I started using the Company Screener. It’s so easy to spot strong companies and avoid cash-burn disasters with the clear financial metrics provided!

FlagPheonix, AZ, USA

Integrating the API has improved our trading models by 25% with real time data on 200+ catalysts. It’s fast, accurate, and has saved us countless hours of manual work!

FlagMunich, Germany

CatalystSync™ saves me hours weekly, tracking 50+ trials for my R&D projects. It’s intuitive, efficient, and has helped uncover trends I might have missed otherwise!

FlagChicago, IL, USA

We’ve already found three partnership opportunities this quarter thanks to CatalystSync™. The pipeline insights and market cap data give us a huge competitive edge!

FlagLondon, UK

Using BiopharmaWatch, we’ve identified two companies with 40%+ returns this year. The PDUFA Calendar alone justifies the subscription-it’s incredibly detailed and actionable!

FlagBoston, MA, USA

The portfolio tracking tools make managing my biotech investments so much smoother. Tracking catalysts and pipelines has helped me make better decisions that really pay off!

FlagBerlin, Germany

The Hedge Fund Screener helped us align with top performing funds, boosting our portfolio by 15%. It’s like having insider knowledge of how major players shape their biotech strategies!

FlagToronto, Canada

Thanks to the searchable FDA Calendar and PDUFA catalysts, I’ve capitalized on key market moving events. This platform has been crucial for generating steady profits!

FlagBoston, MA, USA

The research on over 1,100 companies and clinical trials is simply impressive. It’s helped shape more informed, strategic plans for both my investments and R&D work!

FlagNottingham, UK